Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Foster

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Physics of Fluids (Woodbury, N.Y. : 1994)|March 22, 2021
Estimating COVID-19 exposure in a classroom setting: A comparison between mathematical and numerical modelsAaron Foster, Michael Kinzel
Physics of Fluids (Woodbury, N.Y. : 1994)|November 22, 2021
SARS-CoV-2 transmission in classroom settings: Effects of mitigation, age, and Delta variantAaron Foster, Michael Kinzel
Nanomedicine (London, England)|July 29, 2011
In vivo biodistribution of nanoparticlesJoao Paulo Mattos Almeida, Allen L Chen, Aaron Foster, et al.
Experimental Biology and Medicine (Maywood, N.J.)|August 3, 2021
Stopping the COVID-19 pandemic in dental offices: A review of SARS-CoV-2 transmission and cross-infection preventionMaya Hartig, Carley Stephens, Aaron Foster, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 15, 2020
Ten-year survival rate of 89% after distal femoral osteotomy surgery for lateral compartment osteoarthritis of the kneeFaiz S Shivji, Aaron Foster, Michael J Risebury, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cellsAnn Leen, Maheshika Ratnayake, Aaron Foster, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantationKenneth Micklethwaite, Anna Hansen, Aaron Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemiaEttore Biagi, Raphael Rousseau, Eric Yvon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activityAlana A Kennedy-Nasser, Stephanie Ku, Paul Castillo-Caro, et al.
Plos One|February 23, 2024
Halofuginone for non-hospitalized adult patients with COVID-19 a multicenter, randomized placebo-controlled phase 2 trial. The HALOS trialBruno Martins Tomazini, Lucas Tramujas, Fernando Azevedo Medrado, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Physics of Fluids (Woodbury, N.Y. : 1994)|March 22, 2021
Estimating COVID-19 exposure in a classroom setting: A comparison between mathematical and numerical modelsAaron Foster, Michael Kinzel
Physics of Fluids (Woodbury, N.Y. : 1994)|November 22, 2021
SARS-CoV-2 transmission in classroom settings: Effects of mitigation, age, and Delta variantAaron Foster, Michael Kinzel
Nanomedicine (London, England)|July 29, 2011
In vivo biodistribution of nanoparticlesJoao Paulo Mattos Almeida, Allen L Chen, Aaron Foster, et al.
Experimental Biology and Medicine (Maywood, N.J.)|August 3, 2021
Stopping the COVID-19 pandemic in dental offices: A review of SARS-CoV-2 transmission and cross-infection preventionMaya Hartig, Carley Stephens, Aaron Foster, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 15, 2020
Ten-year survival rate of 89% after distal femoral osteotomy surgery for lateral compartment osteoarthritis of the kneeFaiz S Shivji, Aaron Foster, Michael J Risebury, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cellsAnn Leen, Maheshika Ratnayake, Aaron Foster, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantationKenneth Micklethwaite, Anna Hansen, Aaron Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemiaEttore Biagi, Raphael Rousseau, Eric Yvon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activityAlana A Kennedy-Nasser, Stephanie Ku, Paul Castillo-Caro, et al.
Plos One|February 23, 2024
Halofuginone for non-hospitalized adult patients with COVID-19 a multicenter, randomized placebo-controlled phase 2 trial. The HALOS trialBruno Martins Tomazini, Lucas Tramujas, Fernando Azevedo Medrado, et al.
Pageof 1